|Client||Top 10 company with biologic designed to replace the standard-of-care (“SoC”) oncology product
Scope – Key EU markets
|Company Objectives||Test a variety of potential TPPs with payers to define value, positioning, clinical and economic benefits necessary to optimize P&R.
Gain payer insights on evolving competitive landscape, including biosimilars.
|Project Description||Secondary research to augment company knowledge and develop the “right questions” and TPPs.|
Primary research with payer informant KOLs regarding the existing and evolving landscape. Payer research at a national (country) and regional level (total of >50 interviews).
Key issues explored included:
|Project Outcome||Findings and recommendations used to prioritize fast to market indication possibilities, overall development and endpoints needed to achieve revised P&R goals.|